• Global community
    • Language:
      • Deutsch
      • English
      • Español
      • Français
      • Português
  • 日本語コミュニティ
    Dedicated community for Japanese speakers
  • 한국 커뮤니티
    Dedicated community for Korean speakers
Exit
0

Does the bio Pharma setting of ADOBE SIGN follow other countries requirement as well as 21 CFR 11?

New Here ,
Jun 01, 2020 Jun 01, 2020

Copy link to clipboard

Copied

Hi community members,

Could someone please tell me if the Adobe sign biopharma setting meets the local requirements in countries other than US?

I know Adobe says it is compliant with 21 CFR Part 11 as stated in the link below, however couldn't found about other countries regulations.

Especially I would like to know about ER/ES guideline in Japan.

 

https://helpx.adobe.com/sign/using/bio-pharma-settings-configuration.html

Regards,

Soichiro

TOPICS
Manage security and compliance , Product information

Views

390

Translate

Translate

Report

Report
Community guidelines
Be kind and respectful, give credit to the original source of content, and search for duplicates before posting. Learn more
community guidelines
Community Beginner ,
Aug 08, 2022 Aug 08, 2022

Copy link to clipboard

Copied

LATEST

Hi Community Members

I am single person consultancy busines working in the pharma industry. I currently have  a Creative Cloud All Apps plan which is linked to my single use account. `I would like to set up to be compliant with 21 CFR Part 11 but it would appear I need an enterprise version of Adobe Sign, which does not appear to be available on the current package I'm on. What package can I subscribe to enable compliance to 21 CFR Part 11, as the biopharma pack does not seem to be available to me with the current package I have

REgards

Robert Smith

Votes

Translate

Translate

Report

Report
Community guidelines
Be kind and respectful, give credit to the original source of content, and search for duplicates before posting. Learn more
community guidelines